Lina Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lina Yang has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Huhu Zhang
17 shared publicationsFulin Sun
9 shared publicationsQinghang Song
School of Basic Medicine, Qingdao University, Qingdao, China
9 shared publications- Bing Li
Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, 266071, China
7 shared publications Ya Li
Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, China
7 shared publicationsChunjuan Yu
6 shared publications
Latest Publications
- 11 September 2026
- Published by Oxford University Press (OUP) in Tree Physiology
- Vol. 46 (10)
The dark septate endophyte S16 enhances drought tolerance in sweet cherry by coordinating metabolic reprogramming and the transcription factor PaHB12
Drought severely limits the growth and productivity of sweet cherry (Prunus avium L.), a fruit crop highly sensitive to water deficit. Beneficial root-associated fungi, particularly dark septate endophytes (DSEs), have emerged as potential modulators of stress tolerance, yet their underlying mechanisms in perennial fruit trees remain poorly understood. In this study, we investigated the effects of the DSE fungus Helotiales sp. S16 on drought responses of sweet cherry rootstock Gisela 5 seedlings. Fungal symbiosis was established by homogenizing fungal suspension with sterile growth substrate, and drought stress treatment was implemented 4 weeks after inoculation. Under drought conditions, inoculated seedlings accumulated markedly higher soluble sugar contents, which coincided with upregulated expression of carbohydrate-metabolism-related genes. Lipidomic and transcriptomic data demonstrated that fungal inoculation activated fatty-acid biosynthetic pathways and reshaped overall fatty-acid profiles. Hormone profiling showed elevated abscisic acid, jasmonic acid and salicylic acid levels, accompanied by suppression of auxin (IAA), and cytokinins (6-BA), indicating a reprogramming of hormonal crosstalk. Co-expression network analysis further identified the transcription factor PaHB12 as a regulatory hub in the S16-mediated drought response. These findings demonstrate that DSE fungus S16 enhances drought tolerance through integrated reprogramming of carbon allocation, membrane lipid composition and hormone crosstalk, providing a mechanistic basis for its potential application in sustainable orchard management.
- 11 September 2026
- Published by Oxford University Press (OUP) in Tree Physiology
- Vol. 46 (10)
The dark septate endophyte S16 enhances drought tolerance in sweet cherry by coordinating metabolic reprogramming and the transcription factor PaHB12
Drought severely limits the growth and productivity of sweet cherry (Prunus avium L.), a fruit crop highly sensitive to water deficit. Beneficial root-associated fungi, particularly dark septate endophytes (DSEs), have emerged as potential modulators of stress tolerance, yet their underlying mechanisms in perennial fruit trees remain poorly understood. In this study, we investigated the effects of the DSE fungus Helotiales sp. S16 on drought responses of sweet cherry rootstock Gisela 5 seedlings. Fungal symbiosis was established by homogenizing fungal suspension with sterile growth substrate, and drought stress treatment was implemented 4 weeks after inoculation. Under drought conditions, inoculated seedlings accumulated markedly higher soluble sugar contents, which coincided with upregulated expression of carbohydrate-metabolism-related genes. Lipidomic and transcriptomic data demonstrated that fungal inoculation activated fatty-acid biosynthetic pathways and reshaped overall fatty-acid profiles. Hormone profiling showed elevated abscisic acid, jasmonic acid and salicylic acid levels, accompanied by suppression of auxin (IAA), and cytokinins (6-BA), indicating a reprogramming of hormonal crosstalk. Co-expression network analysis further identified the transcription factor PaHB12 as a regulatory hub in the S16-mediated drought response. These findings demonstrate that DSE fungus S16 enhances drought tolerance through integrated reprogramming of carbon allocation, membrane lipid composition and hormone crosstalk, providing a mechanistic basis for its potential application in sustainable orchard management.
- Open Access
- 15 July 2026
- Published by OAE Publishing Inc. in Journal of Cancer Metastasis and Treatment
- Vol. 12
Immune escape as an ecosystem state in cancer
- 15 July 2026
- Published by OAE Publishing Inc. in Journal of Cancer Metastasis and Treatment
- Vol. 12
Open AccessImmune escape as an ecosystem state in cancer
- Open Access
- 26 June 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Emerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities
Ubiquitin-Specific Protease 14 (USP14) is a proteasome-associated deubiquitinase historically viewed as a pro-tumorigenic driver of the ubiquitin-proteasome system (UPS) by stabilizing oncoproteins. Recent evidence expands this view, positioning USP14 as a central regulator that integrates tumor cell-intrinsic malignancy, tumor microenvironment (TME) remodeling, and resistance to multiple therapies. Importantly, USP14 exerts functions beyond canonical deubiquitination, including non-catalytic and scaffolding activities, and is subject to complex allosteric regulation. This review synthesizes emerging regulatory crosstalks that broaden the functional landscape of USP14 in cancer. We first outline the dynamic allosteric regulatory network of USP14 and its activation modes, emphasizing post-translational modifications (PTMs)-notably phosphorylation and lactylation-that modulate USP14 activity and connectivity beyond traditional links to cell cycle control and metabolism. We then consolidate the signaling frameworks through which USP14 contributes to resistance across therapeutic modalities, including targeted therapies, chemotherapy, radiotherapy, and immunotherapy, highlighting both shared and treatment-specific mechanisms. In parallel, we discuss context-dependent tumor-suppressive roles of USP14 and detail its non-catalytic scaffolding functions that reshape signaling outputs independent of enzymatic activity. Collectively, these classical and non-classical mechanisms depict USP14 as a systems-level coordinator of oncogenic signaling, adaptive stress responses, and microenvironmental interactions. By integrating catalytic and non-catalytic functions with PTM-driven allosteric regulation, we propose a unified regulatory model in which USP14 operates as a master node connecting malignancy, TME dynamics, and therapeutic resistance. This framework provides strategic guidance for developing next-generation allosteric inhibitors and combination strategies aimed at overcoming clinical drug resistance and exploiting context-specific vulnerabilities in USP14-regulated networks.
- 26 June 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessEmerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities
Ubiquitin-Specific Protease 14 (USP14) is a proteasome-associated deubiquitinase historically viewed as a pro-tumorigenic driver of the ubiquitin-proteasome system (UPS) by stabilizing oncoproteins. Recent evidence expands this view, positioning USP14 as a central regulator that integrates tumor cell-intrinsic malignancy, tumor microenvironment (TME) remodeling, and resistance to multiple therapies. Importantly, USP14 exerts functions beyond canonical deubiquitination, including non-catalytic and scaffolding activities, and is subject to complex allosteric regulation. This review synthesizes emerging regulatory crosstalks that broaden the functional landscape of USP14 in cancer. We first outline the dynamic allosteric regulatory network of USP14 and its activation modes, emphasizing post-translational modifications (PTMs)-notably phosphorylation and lactylation-that modulate USP14 activity and connectivity beyond traditional links to cell cycle control and metabolism. We then consolidate the signaling frameworks through which USP14 contributes to resistance across therapeutic modalities, including targeted therapies, chemotherapy, radiotherapy, and immunotherapy, highlighting both shared and treatment-specific mechanisms. In parallel, we discuss context-dependent tumor-suppressive roles of USP14 and detail its non-catalytic scaffolding functions that reshape signaling outputs independent of enzymatic activity. Collectively, these classical and non-classical mechanisms depict USP14 as a systems-level coordinator of oncogenic signaling, adaptive stress responses, and microenvironmental interactions. By integrating catalytic and non-catalytic functions with PTM-driven allosteric regulation, we propose a unified regulatory model in which USP14 operates as a master node connecting malignancy, TME dynamics, and therapeutic resistance. This framework provides strategic guidance for developing next-generation allosteric inhibitors and combination strategies aimed at overcoming clinical drug resistance and exploiting context-specific vulnerabilities in USP14-regulated networks.
- 11 May 2026
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 96 (1) , 46
Synergistic anti-tumor activity of andrographolide and gemcitabine in intrahepatic cholangiocarcinoma through inhibition of RRM2 and the JAK/STAT3 pathway
Purpose Intrahepatic cholangiocarcinoma (ICC) is a lethal malignancy frequently characterized by intrinsic resistance to standard gemcitabine (Gem) chemotherapy. This study aimed to investigate whether andrographolide (Andro) could sensitize intrinsically gemcitabine-resistant ICC cells to gemcitabine and to explore the underlying molecular mechanisms. Methods Naturally Gem-resistant ICC cell lines (HUCCT-1 and QBC-939) were treated with Andro, Gem, or their combination. Synergistic effects were quantified using the Chou-Talalay method. Anti-tumor efficacy was assessed via CCK-8, colony formation, EdU incorporation, wound healing, and Transwell invasion assays. ROS accumulation, apoptosis, mitochondrial membrane potential, and cell-cycle distribution were assessed by fluorescence microscopy and flow cytometry, as appropriate. Molecular targets were identified using molecular docking, RT-qPCR, and Western blotting. Results Andro and Gem exhibited strong synergistic anti-tumor activity (Combination Index < 1.0) in both cell lines. The combination significantly suppressed proliferation, motility, and epithelial-mesenchymal transition. Mechanistically, the synergy was driven by a surge in intracellular ROS, triggering mitochondrial apoptosis and G1/S phase arrest. Furthermore, Ribonucleotide-diphosphate reductase subunit M2 was identified as a candidate molecular target associated with the effects of andrographolide, leading to its downregulation and the subsequent inactivation of the JAK/STAT3 signaling pathway. Conclusion Andrographolide overcomes intrinsic Gem resistance in ICC, potentially through modulation of the RRM2/JAK/STAT3 axis. This combination therapy represents a promising strategy for treating chemoresistant intrahepatic cholangiocarcinoma.
- 11 May 2026
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 96 (1) , 46
Synergistic anti-tumor activity of andrographolide and gemcitabine in intrahepatic cholangiocarcinoma through inhibition of RRM2 and the JAK/STAT3 pathway
Purpose Intrahepatic cholangiocarcinoma (ICC) is a lethal malignancy frequently characterized by intrinsic resistance to standard gemcitabine (Gem) chemotherapy. This study aimed to investigate whether andrographolide (Andro) could sensitize intrinsically gemcitabine-resistant ICC cells to gemcitabine and to explore the underlying molecular mechanisms. Methods Naturally Gem-resistant ICC cell lines (HUCCT-1 and QBC-939) were treated with Andro, Gem, or their combination. Synergistic effects were quantified using the Chou-Talalay method. Anti-tumor efficacy was assessed via CCK-8, colony formation, EdU incorporation, wound healing, and Transwell invasion assays. ROS accumulation, apoptosis, mitochondrial membrane potential, and cell-cycle distribution were assessed by fluorescence microscopy and flow cytometry, as appropriate. Molecular targets were identified using molecular docking, RT-qPCR, and Western blotting. Results Andro and Gem exhibited strong synergistic anti-tumor activity (Combination Index < 1.0) in both cell lines. The combination significantly suppressed proliferation, motility, and epithelial-mesenchymal transition. Mechanistically, the synergy was driven by a surge in intracellular ROS, triggering mitochondrial apoptosis and G1/S phase arrest. Furthermore, Ribonucleotide-diphosphate reductase subunit M2 was identified as a candidate molecular target associated with the effects of andrographolide, leading to its downregulation and the subsequent inactivation of the JAK/STAT3 signaling pathway. Conclusion Andrographolide overcomes intrinsic Gem resistance in ICC, potentially through modulation of the RRM2/JAK/STAT3 axis. This combination therapy represents a promising strategy for treating chemoresistant intrahepatic cholangiocarcinoma.
- 30 April 2026
- Published by Elsevier in Cellular Signalling
- Vol. 144, 112557
The CAMK protein family: Pivotal roles in calcium-dependent disease pathways and emerging therapeutic strategies
- 30 April 2026
- Published by Elsevier in Cellular Signalling
- Vol. 144, 112557
The CAMK protein family: Pivotal roles in calcium-dependent disease pathways and emerging therapeutic strategies
- 17 April 2026
- Published by Springer Nature in Apoptosis
- Vol. 31 (4)
The ATG14: multi-layer autophagy control and an emerging therapeutic target in cancer
ATG14 (ATG14L/Barkor) is the autophagy-specific subunit of class III phosphatidylinositol 3-kinase complex I (PI3KC3-C1) and functions as a pivotal node linking autophagosome formation to autophagosome-lysosome fusion. Functionally, ATG14 regulates cell fate through multiple mechanisms. Under hypoxic or nutrient-deprived conditions, ATG14 maintains tumor cell survival and drug resistance, remodels cellular metabolism via lipophagy and mitophagy, and can either suppress or promote programmed cell death depending on the cellular context. Moreover, ATG14 plays protective roles in maintaining neuronal and hepatic homeostasis and is involved in the development of inflammatory and metabolic disorders. Here, we discuss the multi-layered regulation of ATG14, including post-translational modifications (phosphorylation, ubiquitination, palmitoylation), epitranscriptomic and non-coding RNA regulation, and competitive complex interactions, all of which fine-tune its autophagic output and functional plasticity. We further highlight the central roles of ATG14 during the autophagic process, summarize recent advances in cancer-related ATG14 research, and review ongoing drug development efforts as well as potential therapeutic strategies targeting ATG14. Our goal is to provide a comprehensive understanding of the physiological and pathological functions of ATG14 and to explore its potential as a druggable signaling hub. Given its bidirectional regulatory capacity to either suppress cytoprotective autophagy or enforce lethal autophagy-ATG14-targeted interventions must be strategically designed based on the disease stage and autophagy dependence.
- 17 April 2026
- Published by Springer Nature in Apoptosis
- Vol. 31 (4)
The ATG14: multi-layer autophagy control and an emerging therapeutic target in cancer
ATG14 (ATG14L/Barkor) is the autophagy-specific subunit of class III phosphatidylinositol 3-kinase complex I (PI3KC3-C1) and functions as a pivotal node linking autophagosome formation to autophagosome-lysosome fusion. Functionally, ATG14 regulates cell fate through multiple mechanisms. Under hypoxic or nutrient-deprived conditions, ATG14 maintains tumor cell survival and drug resistance, remodels cellular metabolism via lipophagy and mitophagy, and can either suppress or promote programmed cell death depending on the cellular context. Moreover, ATG14 plays protective roles in maintaining neuronal and hepatic homeostasis and is involved in the development of inflammatory and metabolic disorders. Here, we discuss the multi-layered regulation of ATG14, including post-translational modifications (phosphorylation, ubiquitination, palmitoylation), epitranscriptomic and non-coding RNA regulation, and competitive complex interactions, all of which fine-tune its autophagic output and functional plasticity. We further highlight the central roles of ATG14 during the autophagic process, summarize recent advances in cancer-related ATG14 research, and review ongoing drug development efforts as well as potential therapeutic strategies targeting ATG14. Our goal is to provide a comprehensive understanding of the physiological and pathological functions of ATG14 and to explore its potential as a druggable signaling hub. Given its bidirectional regulatory capacity to either suppress cytoprotective autophagy or enforce lethal autophagy-ATG14-targeted interventions must be strategically designed based on the disease stage and autophagy dependence.
- 21 March 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (5) , 3390-3410
Comprehensive Analysis of the Roles of the CCDC Protein Family Play in a Range of 58 Disease Processes
- 21 March 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (5) , 3390-3410
Comprehensive Analysis of the Roles of the CCDC Protein Family Play in a Range of 58 Disease Processes
- 16 December 2025
- Published by Oxford University Press (OUP) in Tree Physiology
- Vol. 46 (1)
Endophytic fungus Su100 enhances phosphorus solubilization and growth in sweet cherry via organic acids and metabolic reprogramming under phosphorus limitation
Phosphorus is an essential element for plant growth, but it is often present in the soil in an insoluble form, such as calcium phosphate (Ca₃(PO₄)₂), which greatly limits the efficiency of plant absorption and utilization. In this study, the endophytic fungus Su100 was found to significantly increase the solubilization efficiency of Ca₃(PO₄)₂ by secreting various organic acids, such as oxaloacetic acid, malic acid and fumaric acid. Transcriptomic analysis revealed that Su100 participated in the up-regulated expression of genes involved in glycolysis and tricarboxylic acid cycling in Ca₃(PO₄) - containing medium, thereby promoting organic acids biosynthesis and improving phosphorus solubilization. Further experiments showed that inoculation with Su100 promoted the growth of sweet cherry rootstock Gisela 6 seedlings under Ca₃(PO₄)₂ conditions. Furthermore, Su100 inoculation also promoted plant sugar and lipid metabolism, with increased expressions of related genes, indicating that Su100 enhanced sugar and lipid supply to support both plant growth and fungal activity. Meanwhile, fatty acid profiling confirmed increased levels of lignoceric acid, palmitic acid, heptadecanoic acid, stearic acid and other components. These results highlight the potential of Su100 as a biofertilizer to improve phosphorus uptake and sweet cherry growth under Ca₃(PO₄)₂ conditions. The study provides new insights into the molecular mechanisms of plant–fungus interactions and their role in sustainable agriculture.
- 16 December 2025
- Published by Oxford University Press (OUP) in Tree Physiology
- Vol. 46 (1)
Endophytic fungus Su100 enhances phosphorus solubilization and growth in sweet cherry via organic acids and metabolic reprogramming under phosphorus limitation
Phosphorus is an essential element for plant growth, but it is often present in the soil in an insoluble form, such as calcium phosphate (Ca₃(PO₄)₂), which greatly limits the efficiency of plant absorption and utilization. In this study, the endophytic fungus Su100 was found to significantly increase the solubilization efficiency of Ca₃(PO₄)₂ by secreting various organic acids, such as oxaloacetic acid, malic acid and fumaric acid. Transcriptomic analysis revealed that Su100 participated in the up-regulated expression of genes involved in glycolysis and tricarboxylic acid cycling in Ca₃(PO₄) - containing medium, thereby promoting organic acids biosynthesis and improving phosphorus solubilization. Further experiments showed that inoculation with Su100 promoted the growth of sweet cherry rootstock Gisela 6 seedlings under Ca₃(PO₄)₂ conditions. Furthermore, Su100 inoculation also promoted plant sugar and lipid metabolism, with increased expressions of related genes, indicating that Su100 enhanced sugar and lipid supply to support both plant growth and fungal activity. Meanwhile, fatty acid profiling confirmed increased levels of lignoceric acid, palmitic acid, heptadecanoic acid, stearic acid and other components. These results highlight the potential of Su100 as a biofertilizer to improve phosphorus uptake and sweet cherry growth under Ca₃(PO₄)₂ conditions. The study provides new insights into the molecular mechanisms of plant–fungus interactions and their role in sustainable agriculture.
- Open Access
- 2 December 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Deciphering USP8’s pivotal role in cancer: mechanisms, clinical insights and contrasts with its function in pituitary adenomas
The ubiquitin-proteasome system, orchestrated by E1-E2-E3 ubiquitinases, governs protein homeostasis, while deubiquitinating enzymes (DUBs) reverse this pr
- 2 December 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessDeciphering USP8’s pivotal role in cancer: mechanisms, clinical insights and contrasts with its function in pituitary adenomas
The ubiquitin-proteasome system, orchestrated by E1-E2-E3 ubiquitinases, governs protein homeostasis, while deubiquitinating enzymes (DUBs) reverse this pr